BioRegen Biomedical MateRegen® Intrauterine Adhesion Barrier Gel
- Device Class
- CLASS D
- Medical Speciality Area
- General & Plastic Surgery
- Registration Number
- DE0508943
- Registration Date
- February 07, 2024
- Retention Due Date
- February 06, 2026
MateRegen® Gel is indicated for use in patients after hysteroscopic surgeries as barrier to prevent or reduce post-operative intrauterine adhesions. MateRegen® Gel functions to fill intrauterine cavities following surgery, keep the traumatic surfaces separated during the healing process and act as an adjunct to facilitate the natural healing process.
- Short Name
- BioRegen Biomedical (Changzhou) Co., Ltd.
- Address
- Building B, No. 117, Xueye Road, 213125 Changzhou, Jiangsu, CHINA
- Address
- 50 FABER WALK, WATERFRONT @ FABER, #01-36, SINGAPORE 128994
- Address
- 50 FABER WALK, WATERFRONT @ FABER, #01-36, SINGAPORE 128994
- Model Name(s)
- MateRegen® Gel 5ml Pack MateRegen® Gel 3ml Pack
- Model Identifier(s)
- 40-008-005 40-008-011
Access comprehensive regulatory information for BioRegen Biomedical MateRegen® Intrauterine Adhesion Barrier Gel in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0508943 and owned by BioRegen Biomedical (Changzhou) Co., Ltd.. The device was registered on February 07, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.